PARTNER NEWS:Wed, May 1, 9:00 AM, Zacks
ETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts Outlook
Eli Lilly and Company (LLY) raised its outlook for 2024 on rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro.
Thu, Apr 4, 5:00 AM, Zacks
Time to Tap Healthcare ETFs on Nvidia's AI Ambition?
At Nvidia's last week's GTC AI conference, the company announced partnerships in the healthcare sector, representing a strategic move toward expanding its revenue streams beyond tech sectors.